Nagarro at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Nagarro takes part in 1 session at BioTechX Europe 2026 in Basel, and exhibits. Its program centres on how drug companies should get AI agents, software that carries out tasks on its own: build them, buy them or partner. With Daiichi Sankyo and Novo Nordisk, it looks at moving past the hype to real business value.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Nagarro Munich, Germany | |
Digital engineering firm whose life sciences practice builds compliant, scalable digital products for biotech and pharma. | Booth Exhibiting (no floor booth listed) Panel Tue Oct 6 17:25 Build, Buy, or Partner: From Agentic AI Hype to Enterprise Value How drug companies should choose between building, buying or partnering for AI that acts on its own, and how to oversee it. |
Instantly find 20 buyers from Nagarro
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction